What's New

September 22, 2021

HNL Career Fair

Interested in a career at HNL Lab Medicine?

Join us at our next Career Fair, Wednesday, September 29, 2021 at 1 pm – 5:30 pm.

Located at 794 Roble Rd, Allentown, PA 18109-9110 (PARKING LOT)
On-the-spot interviews will be conducted

Read More
September 08, 2021

Martin K. Till, New President and CEO of HNL Lab Medicine, Starts with Strategic Plan to Accelerate Growth

Graphic-HNL-MartinTill-CEO-PR-sm.jpg

HNL Lab Medicine, a regional leader in high quality, innovative laboratory medicine services, announces the official start of Martin K. Till as president and CEO, transitioning from Matthew R. Sorrentino, Esq., who will retire Oct. 15 and continue in a consulting capacity for the next year.

Read More
July 16, 2021

HNL Lab Medicine Announces a New Patient Service Center in Hazleton, Pa.

HNL Lab Medicine, a regional leader in high quality, innovative laboratory medicine services, announces the opening of a patient center at 550 West Broad Street, Hazleton, Luzerne County. Patients can access this facility Monday to Friday from 7 a.m. to 5 p.m. and Saturdays 8 a.m. to noon. https://www.hnl.com/Hazleton 

Read More
July 07, 2021

HNL Lab Medicine Announces New Patient Service Center Location in Gateway Plaza, Chambersburg, Pa.

HNL Lab Medicine, a regional leader in high quality, innovative laboratory medicine services, is moving its Chambersburg patient center to the new Gateway Plaza, 497 Gateway Avenue. Patients can access this facility weekdays from 6 a.m. to 3:30 p.m. and Saturdays 7 a.m. to 11 a.m.
Read More
June 29, 2021

HNL Lab Medicine's Unseen Heroes

Presenting HNL Lab Medicine’s

Unseen Heroes Video — WATCH VIDEO

Read More

Shereen M.F. Gheith, MD, PhD

Chief, Section of Hematopathology Chief, Section of Molecular Pathology
Dr. Gheith received her medical degree from the Ain Shams University School of Medicine, Cairo, where she was also awarded a Master of Science degree in Clinical Pathology, and a PhD in Immunology. She completed both her pathology residency and hematopathology fellowship at the Hospital of the University of Pennsylvania, Philadelphia, Pa. Dr. Gheith is a Diplomate of the American Board of Pathology and is certified in combined Anatomic Pathology and Clinical Pathology, and also board certified in hematopathology. Dr. Shereen Gheith has an academic appointment as Associate Professor of Pathology on the Clinician Educator Pathway at University of South Florida (USF), Morsani College of Medicine.

Publications

Shereen Gheith MD, Chief, Section of Hematopathology & Clinical Laboratory Medicine and Dennis Cornfield, MD, Education Coordinator coauthored a publication entitled “ Promyelocytic sarcoma present with spinal cord compression and treated successfully with surgical debulking and the PETHEMA regimen for acute promyelocytic leukemia ”. Case Reports in Clinical Pathology. 2015; 2(3).

Shereen Gheith MD, Chief, Section of Hematopathology & Clinical Laboratory Medicine coauthored a publication entitled “Primary dural lymphoblastic B-cell lymphoma: a rare subtype of aggressive dural lymphoma”. J Hematopathol. 2015.

Immunoblastic follicular lymphoma: a very unusual transformation of low-grade follicular lymphoma.
Authors: Gheith S; Hematopathology Section, Department of Pathology, Health Network Laboratories/Lehigh Valley Health Network, Allentown, PA, 18103. Electronic address: Shereen_M.Gheith@lvhn.org. Cornfield D; Hematopathology Section, Department of Pathology, Health Network Laboratories/Lehigh Valley Health Network, Allentown, PA, 18103. Chen W; Molecular Diagnostics Section, Cancer Genetics, Rutherford, NJ, 07070. Singh-Kahlon P; Cytogenetics Section, Cancer Genetics, Rutherford, NJ, 07070.
Ahmed B; Hematology/Medical Oncology Section, Department of Medicine, Lehigh Valley Health Network, Allentown, PA, 18103.
Source: Human Pathology [Hum Pathol] 2014 Nov; Vol. 45 (11), pp. 2359-63. Date of Electronic Publication: 2014 Aug 13.

Transformation of the 5q- syndrome to acute lymphoblastic leukemia: a report of two cases and review of the literature.
Agostino NM, Ahmed B, Popescu D. Gheith S, Int J Clin Exp Pathol. 2011 Mar;4(3):322-6. Epub 2011 Mar 22. Review. PMID: 21487529 Free PMC Article

Percentage of {gamma}{delta} T cells in panniculitis by paraffin immunohistochemical analysis.
Roullet M, Gheith SM, Mauger J, Junkins-Hopkins JM, Choi JK. Am J Clin Pathol. 2009 Jun;131(6):820-6. doi: 10.1309/AJCPMG37MXKYPUBE. PMID: 19461088 Free Article

Small lymphocytic lymphoma/chronic lymphocytic leukemia in a pelvic myelolipoma.
Gheith S, Boulay R, Cornfield D. Int J Clin Exp Pathol. 2009;2(1):95-8. Epub 2008 Jan 31. PMID: 18830383 [PubMed] Free PMC Article

Flow cytometric quantitation of natural killer cells and T lymphocytes expressing T-cell receptors alpha/beta and gamma/delta is not helpful in distinguishing benign from malignant body cavity effusions.
Cornfield DB, Gheith SM. Cytometry B Clin Cytom. 2009 May;76(3):213-7. doi: 10.1002/cyto.b.20455. PMID: 18803280 Free Article

A third case of chronic eosinophilic leukemia with the (8;9)(p23;p24) translocation.
Cornfield DB, Gheith SM, Friedman EL. Cancer Genet Cytogenet. 2008 Aug;185(1):60-1. doi: 10.1016/j.cancergencyto.2008.04.018. No abstract available. PMID: 18656698

Adhesion- and degranulation-promoting adapter protein is required for efficient thymocyte development and selection.
Wu JN, Gheith S, Bezman NA, Liu QH, Fostel LV, Swanson AM, Freedman BD, Koretzky GA, Peterson EJ.
J Immunol. 2006 Jun 1;176(11):6681-9. PMID: 16709827
 Free Article

PRAM-1 is required for optimal integrin-dependent neutrophil function.
Clemens RA, Newbrough SA, Chung EY, Gheith S, Singer AL, Koretzky GA, Peterson EJ.
Mol Cell Biol. 2004 Dec;24(24):10923-32. PMID: 15572693
 Free PMC Article

Recruitment of SLP-76 to the membrane and glycolipid-enriched membrane microdomains replaces the requirement for linker for activation of T cells in T cell receptor signaling. 
Boerth NJ, Sadler JJ, Bauer DE, Clements JL, Gheith SM, Koretzky GA. J Exp Med. 2000 Oct 2;192(7):1047-58.PMID:11015445 Free PMC Article